Boston Scientific (BSX) EPS (Basic) Growth (1y) (2010 - 2026)
Boston Scientific (BSX) EPS (Basic) Growth (1y) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.08 Bn | 194.48 Bn | 7.27 Bn | -47.75% |
| 2 | Stryker | 129.71 Bn | 126.23 Bn | 4.50 Bn | 43.85% |
| 3 | Medtronic | 120.07 Bn | 110.85 Bn | 6.41 Bn | 18.90% |
| 4 | Boston Scientific | 74.08 Bn | 73.54 Bn | 3.85 Bn | 14.55% |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.43 Bn | 1.35 Bn | -25.84% |
| 6 | Dexcom | 34.51 Bn | 32.56 Bn | 830.00 Mn | 42.13% |
| 7 | GE HealthCare Technologies | 34.03 Bn | 31.92 Bn | 2.18 Bn | 15.81% |
| 8 | Koninklijke Philips | 26.51 Bn | 23.19 Bn | 4.55 Bn | 72.17% |
| 9 | Steris | 23.20 Bn | 22.72 Bn | 684.20 Mn | 13.85% |
| 10 | Zimmer Biomet Holdings | 19.37 Bn | 18.96 Bn | 1.54 Bn | 33.98% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 14.55% |
| Mar 31, 2026 | 97.93% |
| Dec 31, 2025 | 18.22% |
| Sep 30, 2025 | 60.00% |
| Jun 30, 2025 | 144.44% |
| Mar 31, 2025 | 35.35% |
| Dec 31, 2024 | 10.47% |
| Sep 30, 2024 | -7.65% |
| Jun 30, 2024 | 22.08% |
| Mar 31, 2024 | 61.34% |
| Dec 31, 2023 | 294.59% |
| Sep 30, 2023 | 183.71% |
| Jun 30, 2023 | 4.89% |
| Mar 31, 2023 | 207.56% |
| Dec 31, 2022 | 56.60% |
| Sep 30, 2022 | -57.27% |
| Jun 30, 2022 | 42.18% |
| Mar 31, 2022 | -70.53% |
| Dec 31, 2021 | -59.34% |
| Sep 30, 2021 | 340.84% |